Anatomical Therapeutic Chemical • L02BB06 • darolutamide

L Antineoplastic and immunomodulating agents

L01 Antineoplastic agents

L02 Endocrine therapy

L02A Hormones and related agents

L02B Hormone antagonists and related agents

L02BA Anti-estrogens

L02BB Anti-androgens

L02BB01 flutamide Indicated for: prostate cancer

L02BB03 bicalutamide Indicated for: prostate cancer

L02BB04 enzalutamide Indicated for: prostate cancer

L02BB05 apalutamide Indicated for: prostate cancer

L02BB06 darolutamide Indicated for: prostate cancer

L02BG Aromatase inhibitors

L02BX Other hormone antagonists and related agents

L03 Immunostimulants

L04 Immunosuppressants